Aquinox Pharmaceuticals, Inc.
NOTICE DECLARING INTENTION TO BE QUALIFIED UNDER
NATIONAL INSTRUMENT 44-101
SHORT FORM PROSPECTUS DISTRIBUTIONS
December 22, 2015
To: British Columba Securities Commission
Aquinox Pharmaceuticals, Inc. (the “Issuer”) intends to be qualified to file a short form
prospectus under NI 44-101. The Issuer acknowledges that it must satisfy all applicable qualification
criteria prior to filing a preliminary short form prospectus. This notice does not evidence the Issuer’s
intent to file a short form prospectus, to enter into any particular financing or transaction or to
become a reporting issuer in any jurisdiction. This notice will remain in effect until withdrawn by the
AQUINOX PHARMACEUTICALS, INC.
By: “Kamran Alam” Name: Kamran Alam Title: Vice President, Finance and Chief Financial Officer
MT DOCS 15127601v1